Home >> MARKETPLACE (page 5)

MARKETPLACE

New pathology lab products and industry news

FDA expands approval of olaparib

February 2019—Olaparib (Lynparza, AstraZeneca) has been approved by the FDA for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line, platinum-based chemotherapy.

Read More »

Sample prep kit for FFPE tissue analysis

January 2019—Menarini Silicon Biosystems announced the launch of its DEPArray FFPE Sample­Prep Kit at the Association for Molecular Pathology’s annual meeting. The kit allows for the disaggregation and staining of formalin-fixed, paraffin-embedded tissue sections down to a single-cell suspension. The kit enables the detection, identification, and recovery of different cell populations by the DEPArray system based on specific immunofluorescent staining and DNA content. It has been tested using FFPE human tissue sections of primary and metastatic keratin-positive carcinomas in lung, breast, colon, pancreas, prostate, and ovarian tissues.

Read More »
X